These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19781269)
81. [Expression and related factors of Galectin-3 in non-small cell lung cancer]. Liu M; Du B; Li C; Zhao Y; Meng Q; Cai L Zhongguo Fei Ai Za Zhi; 2013 Aug; 16(8):417-21. PubMed ID: 23945245 [TBL] [Abstract][Full Text] [Related]
82. N-glycans and metastasis in galectin-3 transgenic mice. More SK; Srinivasan N; Budnar S; Bane SM; Upadhya A; Thorat RA; Ingle AD; Chiplunkar SV; Kalraiya RD Biochem Biophys Res Commun; 2015 May; 460(2):302-7. PubMed ID: 25791476 [TBL] [Abstract][Full Text] [Related]
83. Upregulation of cytoskeleton protein and extracellular matrix protein induced by stromal-derived nitric oxide promotes lung cancer invasion and metastasis. Zhang L; Liu J; Wang X; Li Z; Zhang X; Cao P; She X; Dai Q; Tang J; Liu Z Curr Mol Med; 2014; 14(6):762-71. PubMed ID: 25056538 [TBL] [Abstract][Full Text] [Related]
84. [Pathological basis of qi-deficiency and blood stasis syndrome in patients with non-small cell lung cancer viewing from tumor metastasis related factors]. Luo XQ; Xu YM; Tang Y Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Oct; 29(10):886-8. PubMed ID: 20073217 [TBL] [Abstract][Full Text] [Related]
85. Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer. Boldrini L; Donati V; Dell'Omodarme M; Prati MC; Faviana P; Camacci T; Lucchi M; Mussi A; Santoro M; Basolo F; Fontanini G Br J Cancer; 2005 Aug; 93(4):453-7. PubMed ID: 16091764 [TBL] [Abstract][Full Text] [Related]
86. Role of osteopontin in lung cancer evolution and heterogeneity. Shi L; Wang X Semin Cell Dev Biol; 2017 Apr; 64():40-47. PubMed ID: 27578008 [TBL] [Abstract][Full Text] [Related]
87. Comparison of the diagnostic value of CEA combined with OPN or DKK1 in non-small cell lung cancer. Sun J; Chen X; Wang Y Oncol Lett; 2020 Sep; 20(3):3046-3052. PubMed ID: 32782622 [TBL] [Abstract][Full Text] [Related]
88. Plasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancer. Han SS; Lee SJ; Kim WJ; Ryu DR; Won JY; Park S; Cheon MJ Tuberc Respir Dis (Seoul); 2013 Sep; 75(3):104-10. PubMed ID: 24101934 [TBL] [Abstract][Full Text] [Related]
89. Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancer. Ouyang X; Huang Y; Jin X; Zhao W; Hu T; Wu F; Huang J Onco Targets Ther; 2018; 11():5933-5941. PubMed ID: 30275702 [TBL] [Abstract][Full Text] [Related]
90. Elevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer. Liang Y; Li H; Hu B; Chen X; Miao JB; Li T; You B; Chen QR; Fu YL; Wang Y; Hou SC Chin J Cancer Res; 2011 Mar; 23(1):64-8. PubMed ID: 23467432 [TBL] [Abstract][Full Text] [Related]
91. Plasma Osteopontin Levels is Associated with Biochemical Markers of Kidney Injury in Patients with Leptospirosis. Chagan-Yasutan H; Hanan F; Niki T; Bai G; Ashino Y; Egawa S; Telan EFO; Hattori T Diagnostics (Basel); 2020 Jun; 10(7):. PubMed ID: 32610429 [No Abstract] [Full Text] [Related]
92. Dynamics of Heat Shock Protein 70 Serum Levels As a Predictor of Clinical Response in Non-Small-Cell Lung Cancer and Correlation with the Hypoxia-Related Marker Osteopontin. Ostheimer C; Gunther S; Bache M; Vordermark D; Multhoff G Front Immunol; 2017; 8():1305. PubMed ID: 29093708 [TBL] [Abstract][Full Text] [Related]
93. Expressions of Osteopontin (OPN), ανβ3 and Pim-1 Associated with Poor Prognosis in Non-small Cell Lung Cancer (NSCLC). Jin Y; Tong DY; Tang LY; Chen JN; Zhou J; Feng ZY; Shao CK Chin J Cancer Res; 2012 Jun; 24(2):103-8. PubMed ID: 23359766 [TBL] [Abstract][Full Text] [Related]
94. Elevated Levels of Galectin-9 but Not Osteopontin in HIV and Tuberculosis Infections Indicate Their Roles in Detecting MTB Infection in HIV Infected Individuals. Shete A; Bichare S; Pujari V; Virkar R; Thakar M; Ghate M; Patil S; Vyakarnam A; Gangakhedkar R; Bai G; Niki T; Hattori T Front Microbiol; 2020; 11():1685. PubMed ID: 32765475 [TBL] [Abstract][Full Text] [Related]
95. [Osteopontin and male reproduction]. Liu Q; Xie QZ Zhonghua Nan Ke Xue; 2012 May; 18(5):446-9. PubMed ID: 22741446 [TBL] [Abstract][Full Text] [Related]
96. Clinical significance of galectin-3 expression in malformed hepatic venous tissue. Qiao J; Chen Y; Dong C; Li J Indian J Med Res; 2018 Dec; 148(6):728-733. PubMed ID: 30778007 [TBL] [Abstract][Full Text] [Related]
98. Galectin-1 and immune suppression during radiotherapy. Welsh JW; Seyedin SN; Cortez MA; Maity A; Hahn SM Clin Cancer Res; 2014 Dec; 20(24):6230-2. PubMed ID: 25348514 [TBL] [Abstract][Full Text] [Related]
99. [Progress of aquaporin 5 on tumor development and metastasis]. Zhao R; Pan Y; Li XJ Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):231-4. PubMed ID: 23019930 [No Abstract] [Full Text] [Related]
100. The increase of plasma galectin-9 in a patient with insulin allergy: a case report. Chagan-Yasutan H; Shiratori B; Siddiqi UR; Saitoh H; Ashino Y; Arikawa T; Hirashima M; Hattori T Clin Mol Allergy; 2010 Aug; 8():12. PubMed ID: 20699002 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]